BROADWOOD CAPITAL INC
CIK
1278387
Location
New York, NY
Portfolio Value
Mid
$1,300,973,754
Diversification
Highly concentrated
Filing Date
Global Rank
#1,287
/ 8,232
▼ 63
Top Industry
Beverages - Non-Alcoholic
45.2%
3Y Alpha vs SPY
-15.8%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+17.5%
SPY
+76.3%
Annualised alpha
-15.3%
Max drawdown
−29.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
5 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
45.2%
+5.5 pts
Top 5
100.0%
+3.0 pts
Top 10
100.0%
+0.0 pts
HHI
3,134
Highly concentrated+407
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Consumer Defensive | 45.2% | $587,490,898 |
| Healthcare | 32.2% | $418,958,643 |
| Industrials | 22.6% | $294,524,213 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MNST | Monster Beverage Corp | −91,200 | 8,107,796 | $587,490,898 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| UAL | United Airlines Holdings, Inc. | 150,000 | $16,773,000 | |
| AAL | American Airlines Group Inc. | 820,000 | $12,570,600 | |
| LUV | Southwest Airlines Co | 183,000 | $7,563,390 | |
| GIL | Gildan Activewear Inc. | 112,750 | $7,042,365 | |
| DAL | Delta Air Lines, Inc. | 52,500 | $3,643,500 | |
| SER | Serina Therapeutics, Inc. | 54,484 | $104,227 | |
| No positions match the current search. | ||||
5 positions ·
$1,300,973,754 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MNST |
Monster Beverage Corp
Consumer Defensive
|
Reduced | 8,107,796 | $587,490,898 | 45.16% | |
| STAA |
Staar Surgical Co
Healthcare
|
Added | 16,123,842 | $301,515,845 | 23.18% | |
| AXON |
Axon Enterprise, Inc.
Industrials
|
Held | 693,504 | $294,524,213 | 22.64% | |
| LCTX |
Lineage Cell Therapeutics, Inc.
Healthcare
|
Held | 49,560,992 | $78,306,367 | 6.02% | |
| IMDX |
Insight Molecular Diagnostics Inc.
Healthcare
|
Added | 11,931,839 | $39,136,431 | 3.01% |